Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1467243

registered interest
date	01/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact of the decision to end free access to lateral flow tests on the rates of covid-19 (a) infection, (b) severe illness and (c) death for people who are (i) at highest risk of developing severe covid-19 and (ii) clinically vulnerable to covid-19; and if the Government will reinstate the provision of free lateral flow covid-19 tests.
tabling member constituency	Coventry South
tabling member printed	Zarah Sultana
uin	11884
answer	answer is ministerial correction date of answer 08/06/2022 answer text <p>The most recent data indicates that rates of infection, hospitalisation and deaths in England have declined in the last month. We will continue to monitor prevalence and other factors to determine whether additional testing may be required.</p><p>For those who are immunosuppressed, testing to support effective COVID-19 treatments remains available. We will keep data on rates of infection, severe illness and death among all groups under review, including those whose immune systems mean they are at higher risk from COVID-19.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 08/06/2022 15:11:08 answering member 4447 label Biography information for Maggie Throup
tabling member	4786 label Biography information for Zarah Sultana

1466519

registered interest
date	26/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of providing third sector contractors carrying out NHS contracts with free lateral flow covid-19 test kits.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	9996
answer	answer is ministerial correction date of answer 06/06/2022 answer text <p>Free symptomatic and asymptomatic testing is available in the health sector based on clinical risk factors. Those who regularly work with National Health Service patients are eligible for free lateral flow tests through the staff testing programme. This includes individuals not directly employed by a NHS organisation, such as volunteers in vaccination centres in patient-facing roles. The decision on whether a role is patient-facing is made locally.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/06/2022 09:22:44 answering member 4447 label Biography information for Maggie Throup
tabling member	4656 label Biography information for Layla Moran

1465672

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made a recent estimate of the number and proportion of covid-19 lateral flow test results that are not registered with the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	9006
answer	answer is ministerial correction date of answer 06/06/2022 answer text <p>No recent estimate has been made.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/06/2022 16:20:45 answering member 4447 label Biography information for Maggie Throup
tabling member	4131 label Biography information for Jim Shannon

1465721

registered interest
date	25/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to work with private covid-19 lateral flow test providers to ensure that tests are affordable; and if he will make a statement.
tabling member constituency	Eastbourne
tabling member printed	Caroline Ansell
uin	9071
answer	answer is ministerial correction date of answer 06/06/2022 answer text <p>Manufacturers and retailers of devices have autonomy to determine the pricing of lateral flow device tests and the pack sizes available. However, the Government has engaged with manufacturers and retailers on setting affordable prices to ensure a private market exists and flourishes.</p><p><strong> </strong></p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/06/2022 16:32:04 answering member 4447 label Biography information for Maggie Throup
tabling member	4512 label Biography information for Caroline Ansell

1464927

registered interest
date	23/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of the UK Health Security Agency’s Coronavirus test device approval (CTDA) process for covid-19 diagnostics, in helping UK manufacturers to be world-leaders in clinical diagnostics delivery.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	6913
answer	answer is ministerial correction date of answer 07/06/2022 answer text <p>The Coronavirus Test Device Approval (CTDA) validation process has ensured that the highest quality COVID-19 tests are available on the United Kingdom market. As of 24 May 2022, 244 applications for review under CTDA regulations have been received, with 143 or 58% originating from manufacturers in the UK. The CTDA validation process applies equally to both foreign and domestic manufacturers.</p><p>While there are no plans to provide specific weekly updates, the UK Health Security Agency (UKHSA) frequently communicates with applicants through its dedicated review and complaint channels. The UKHSA keeps the CTDA process under continuous review and will consider further improvements for applicants.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 6924 6925 question first answered 07/06/2022 09:39:58 answering member 4447 label Biography information for Maggie Throup
tabling member	4769 label Biography information for Daisy Cooper

1465152

registered interest
date	23/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason foreign-manufactured PCR tests are not subject to the same Coronavirus Test Device Approvals (CTDA) process to which UK manufactured tests must comply.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	6924
answer	answer is ministerial correction date of answer 07/06/2022 answer text <p>The Coronavirus Test Device Approval (CTDA) validation process has ensured that the highest quality COVID-19 tests are available on the United Kingdom market. As of 24 May 2022, 244 applications for review under CTDA regulations have been received, with 143 or 58% originating from manufacturers in the UK. The CTDA validation process applies equally to both foreign and domestic manufacturers.</p><p>While there are no plans to provide specific weekly updates, the UK Health Security Agency (UKHSA) frequently communicates with applicants through its dedicated review and complaint channels. The UKHSA keeps the CTDA process under continuous review and will consider further improvements for applicants.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 6913 6925 question first answered 07/06/2022 09:39:58 answering member 4447 label Biography information for Maggie Throup
tabling member	4769 label Biography information for Daisy Cooper

1465154

registered interest
date	23/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make It his policy to provide applicants to the Coronavirus Test Device Approvals (CTDA) service with weekly status updates on their applications.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	6925
answer	answer is ministerial correction date of answer 07/06/2022 answer text <p>The Coronavirus Test Device Approval (CTDA) validation process has ensured that the highest quality COVID-19 tests are available on the United Kingdom market. As of 24 May 2022, 244 applications for review under CTDA regulations have been received, with 143 or 58% originating from manufacturers in the UK. The CTDA validation process applies equally to both foreign and domestic manufacturers.</p><p>While there are no plans to provide specific weekly updates, the UK Health Security Agency (UKHSA) frequently communicates with applicants through its dedicated review and complaint channels. The UKHSA keeps the CTDA process under continuous review and will consider further improvements for applicants.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 6913 6924 question first answered 07/06/2022 09:39:58 answering member 4447 label Biography information for Maggie Throup
tabling member	4769 label Biography information for Daisy Cooper

1462768

registered interest
date	13/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the income generated from desktop review fees submitted by companies applying to the Coronavirus Test Devices Approval (CTDA) process has been reinvested to ensure that the newly introduced regulator operates proficiently and at a high standard.
tabling member constituency	Tatton
tabling member printed	Esther McVey
uin	1503
answer	answer is ministerial correction date of answer 20/05/2022 answer text <p>The Coronavirus Test Devices Approval (CTDA) process operates on a cost recovery basis and does not generate any income from its desktop review fees, in excess of expenses incurred in the carrying out of its core duties. All revenue generated is offset against the cost of running the CTDA process.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 20/05/2022 09:20:55 answering member 4447 label Biography information for Maggie Throup
tabling member	4084 label Biography information for Esther McVey

1462573

registered interest
date	12/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of trends in the level of covid-19 tests available on the market that have not been approved by his Department.
tabling member constituency	Enfield North
tabling member printed	Feryal Clark
uin	1384
answer	answer is ministerial correction date of answer 25/05/2022 answer text <p>Reports of non-compliance with the Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 remain consistently low. All reports of non-compliant COVID-19 tests are reviewed by the Medicines and Healthcare products Regulatory Agency and relevant regulatory action taken where necessary.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 25/05/2022 16:12:31 answering member 4447 label Biography information for Maggie Throup
tabling member	4822 label Biography information for Feryal Clark

1462652

registered interest
date	12/05/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether companies that paid the mandatory desktop review fee to submit an individual application to the Coronavirus Test Devices Approval process will be reimbursed if no outcome is given by the UK Security Agency before the 31 May temporary protocol deadline.
tabling member constituency	Tatton
tabling member printed	Esther McVey
uin	1169
answer	answer is ministerial correction date of answer 18/05/2022 answer text <p>The fee is charged to assess an applicant test to ensure it is safe and of sufficient quality to enter the United Kingdom market. It is not related to the 31 May temporary protocol deadline therefore no reimbursement will be made.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 18/05/2022 14:06:31 answering member 4447 label Biography information for Maggie Throup
tabling member	4084 label Biography information for Esther McVey